Xiao Lu Selected Research

Hypoxia (Hypoxemia)

1/2022	Pulmonary Thrombosis Promotes Tumorigenesis via Myeloid Hypoxia-Inducible Factors.
10/2020	Network pharmacology-based therapeutic mechanism of Kuanxiong aerosol for angina pectoris.
1/2018	DJ-1 promotes survival of human colon cancer cells under hypoxia by modulating HIF-1α expression through the PI3K-AKT pathway.
5/2017	Modelling pulmonary microthrombosis coupled to metastasis: distinct effects of thrombogenesis on tumorigenesis.
11/2015	Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Lu Research Topics

Disease

39	Neoplasms (Cancer) 05/2024 - 07/2010
14	Inflammation (Inflammations) 03/2024 - 05/2010
11	Stroke (Strokes) 01/2023 - 03/2014
10	Infections 12/2023 - 10/2009
9	COVID-19 04/2024 - 01/2020
8	Fibrosis (Cirrhosis) 01/2024 - 01/2016
7	Carcinogenesis 10/2023 - 07/2010
7	Malaria 01/2022 - 05/2015
6	Adenocarcinoma of Lung 09/2023 - 07/2010
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2011
6	Heart Failure 01/2023 - 07/2018
6	Neoplasm Metastasis (Metastasis) 10/2022 - 07/2010
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 10/2008
5	Myocardial Infarction 12/2023 - 01/2015
5	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 01/2022
5	Hypoxia (Hypoxemia) 01/2022 - 11/2015
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2018 - 12/2014
4	Thrombosis (Thrombus) 01/2024 - 09/2014
4	Ischemia 12/2023 - 10/2008
4	Insulin Resistance 11/2023 - 06/2011
4	Necrosis 10/2023 - 01/2016
4	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2010
4	Mannose-Binding Protein Deficiency 01/2022 - 01/2019
4	Infarction (Infarctions) 01/2022 - 02/2011
4	Hypertension (High Blood Pressure) 01/2021 - 06/2011
3	Wounds and Injuries (Trauma) 05/2024 - 10/2020
3	Intervertebral Disc Degeneration 05/2024 - 01/2023
3	Ischemic Stroke 03/2024 - 01/2021
3	Pneumonia (Pneumonitis) 01/2024 - 01/2022
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 01/2020
3	Weight Loss (Weight Reduction) 05/2023 - 09/2011
3	Cognitive Dysfunction 01/2023 - 02/2011
3	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 12/2017
3	Hepatitis 12/2021 - 01/2013
3	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021 - 01/2016
3	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2011
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 12/2014
2	Neuroinflammatory Diseases 03/2024 - 12/2023
2	Acute Lung Injury 03/2024 - 02/2013
2	Chronic Renal Insufficiency 01/2024 - 10/2008
2	Colitis 12/2023 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 11/2023 - 06/2011
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2021
2	Persistent Vegetative State (Vegetative State) 01/2023 - 01/2022
2	Virus Diseases (Viral Diseases) 12/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 05/2024 - 05/2010
9	Therapeutic UsesIBA 12/2023 - 07/2011
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 10/2008
8	salicylhydroxamic acid (SHAM)IBA 12/2023 - 10/2008
8	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2011
8	VaccinesIBA 01/2022 - 08/2010
7	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 11/2023 - 01/2017
6	CytokinesIBA 01/2022 - 02/2013
6	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2010
5	LipopolysaccharidesIBA 01/2024 - 05/2010
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2010
5	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 03/2014
4	Oxygen (Dioxygen)IBA 05/2023 - 02/2020
4	Alanine Transaminase (SGPT)IBA 10/2022 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2021 - 02/2013
3	CollagenIBA 05/2024 - 04/2012
3	CalciumIBA 05/2024 - 12/2021
3	Mannose (D-Mannose)IBA 12/2023 - 01/2022
3	Long Noncoding RNAIBA 12/2023 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 10/2020
3	Monoclonal AntibodiesIBA 01/2023 - 02/2004
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2020
3	AerosolsIBA 01/2022 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 05/2010
3	Concanavalin AIBA 12/2021 - 01/2013
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2021 - 01/2016
3	Indicators and Reagents (Reagents)IBA 04/2021 - 10/2015
3	Antiparasitic Agents (Antiparasitics)IBA 01/2021 - 12/2020
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2020 - 05/2018
3	AntigensIBA 05/2019 - 08/2010
3	Insulin (Novolin)FDA Link 01/2019 - 06/2011
3	Immunoglobulin G (IgG)IBA 01/2017 - 05/2014
2	Silicon Dioxide (Silica)FDA LinkGeneric 05/2024 - 01/2022
2	tricalcium phosphateIBA 05/2024 - 10/2019
2	SodiumIBA 01/2024 - 01/2021
2	Biocompatible Materials (Biomaterials)IBA 01/2024 - 09/2020
2	6-methyladenineIBA 10/2023 - 10/2022
2	Lysine (L-Lysine)FDA Link 10/2023 - 07/2018
2	Transcription Factors (Transcription Factor)IBA 10/2023 - 05/2017
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2023 - 12/2014
2	LipidsIBA 01/2023 - 01/2021
2	Neuroprotective AgentsIBA 01/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2021

Therapy/Procedure

31	Therapeutics 04/2024 - 07/2010
7	Drug Therapy (Chemotherapy) 01/2023 - 03/2012
3	Activities of Daily Living (ADL) 01/2023 - 01/2021
3	Cognitive Training 01/2023 - 01/2018
3	Immunotherapy 01/2023 - 05/2019
3	Resuscitation 10/2022 - 02/2020
3	Length of Stay 01/2022 - 05/2020
2	Vagus Nerve Stimulation 03/2024 - 01/2023
2	Ligation 12/2023 - 02/2013
2	Transplantation 02/2023 - 01/2014
2	Radiotherapy 01/2023 - 12/2022
2	Transcranial Direct Current Stimulation 01/2023 - 01/2022